---
schema_version: "secwatch.filing_event.v1"
accession: "0001641489-24-000045"
form_type: "8-K"
ticker: "VTVT"
cik: "0001641489"
company_name: "vTv Therapeutics Inc."
filed_at: "2024-06-14T23:59:59+00:00"
generated_at: "2026-06-01T04:20:35.264857+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# vTv Therapeutics stockholders elect seven directors and approve 2024 Equity Incentive Plan

## Summary
- At the June 11, 2024 annual meeting, stockholders elected Srinivas Akkaraju, Raymond Cheong, Fahed Al Marzooqi, Richard Nelson, Anne Phillips, Paul Sekhri, and Daniel Spiegelman as directors.
- Stockholders approved the 2024 Equity Incentive Plan with 1,814,842 votes for, 103,928 against, and 1,925 abstentions.
- Ernst & Young LLP was ratified as independent auditor for fiscal 2024 with 2,106,193 votes for, 9,580 against, and 99,191 abstentions.
- All director nominees received between 1,887,098 and 1,913,689 votes for, with 294,269 broker non-votes each.

## SEC filing metadata
- accession: 0001641489-24-000045
- form_type: 8-K
- ticker: VTVT
- cik: 0001641489
- company_name: vTv Therapeutics Inc.
- filed_at: 2024-06-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1641489/000164148924000045/0001641489-24-000045-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1641489/000164148924000045/vtvt-20240611.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641489-24-000045
- JSON: https://secwatch.observer/filing/0001641489-24-000045.json
- Plain text: https://secwatch.observer/filing/0001641489-24-000045.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.